These TCR signatures contrast with an early report demonstrating the expansion of VA-22 and VB-11-ISGSY dominant clonotypes derived from the blister fluid of SJS/TEN patients recruited in Taiwan expressing HLA-B*15:02 (28). This evidence concerns the gene HLA-B and Schwartz-Jampel syndrome.